Page last updated: 2024-09-03

a 68930 and Alloxan Diabetes

a 68930 has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cheng, ZY; He, L; Hu, YH; Wang, C; Xia, QP	1

Other Studies

1 other study(ies) available for a 68930 and Alloxan Diabetes

Article	Year
DRD1 agonist A-68930 improves mitochondrial dysfunction and cognitive deficits in a streptozotocin-induced mouse model. Brain research bulletin, 2021, Volume: 175 Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Chromans; Cognition Disorders; Diabetes Mellitus, Experimental; Dopamine Agonists; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Mitochondria; Organelle Biogenesis; Receptors, Dopamine D1; tau Proteins	2021

Article

Year

DRD1 agonist A-68930 improves mitochondrial dysfunction and cognitive deficits in a streptozotocin-induced mouse model.

Brain research bulletin, 2021, Volume: 175

Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Chromans; Cognition Disorders; Diabetes Mellitus, Experimental; Dopamine Agonists; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Mitochondria; Organelle Biogenesis; Receptors, Dopamine D1; tau Proteins

2021